← FDA Drug Approvals (Drugs@FDA)

BLEOMYCIN SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 2000-03-10

Drug application

FDA Application #

ANDA065031

Application type

Abbreviated New Drug Application (Generic)

Brand name

BLEOMYCIN SULFATE

Generic name

BLEOMYCIN

Active ingredients

BLEOMYCIN SULFATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

HOSPIRA

Manufacturer

Hospira, Inc.

First approval

2000-03-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown